Users and funds drawn into digital revolution in mental health

South Korean pharmaceutical giant Celltrion Inc. said Thursday its new biosimilar of the arthritis drug Humira has won approval from Canadian authorities. Yuflyma, an adalimumab biosimilar with a high concentration, is used to treat patients with rheumatoid arthritis, psoriasis and inflammatory diseases. Yuflyma requires only half the solution administered to patients compared with the existing Humira biosimilar and is also citrate-free, which lessens discomfort during injection. Celltrion re

A slimmer cochlear implant device design and its early activation are likely to lead to better hearing in cochlear implant patients, according to professor Choi Byung-Yoon, an otorhinolaryngology specialist. Cochlear implants, which remains the only way to restore hearing for people with severe to profound deafness, work by translating sound into electrical signals that can be registered by auditory nerves. The implant consists of external components worn outside, much like a hearing aid,

Singer and entertainer Kim Jong-kook has enjoyed over two decades of success in TV and music. But the 45-year-old recently made headlines for something other than his voice: his workout routine. Controversy broke out one faithful Halloween to spook fans of the beloved TV personality, when a fitness YouTuber named Greg Doucette called him out for likely not being “natural” when working out to build his body. “Is he natural? Of course not!” Doucette said in his video. He

It happened back in 2014 when I was in Geneva, Switzerland, serving as a delegate of Permanent Mission of the Republic of Korea. I had a skin rash so I visited a local hospital, where they tested my antimicrobial susceptibility before giving me any treatment. The hospital ran this test to see if there were any antibiotics that my body was resistant to. Little did I know before I got tested that there were not many effective antibiotics left for me. Fewer antibiotic options meant fewer treatm

Wrongly administering COVID-19 vaccines into blood vessels instead of the muscles could be behind the serious side effects, some studies have suggested. An Aug. 2 report published by the Journal of Korean Medical Sciences is one of the first in the country to suggest that technique known as aspiration -- which is pulling back on the syringe plunger before injecting the vaccine to ensure no blood vessel is accidentally punctured -- may provide better chances of avoiding side effects. The rep

Sobering findings of the past few weeks have shaken both the American and scientific psyche. People have had to reassess their perceptions about the COVID-19 vaccines, and the reemergence of an epidemic many thought was over. Many of us have had to come to terms with how life can sometimes just be complicated. It’s been a scientific and emotional roller coaster. In the spring, we saw the alpha variant, which was two times more infectious than the ancestral strain. That was followed by be

With fall just around the corner, concerns are once again rising of a possible “twindemic” -- a COVID-19 pandemic coupled with flu endemic -- which never materialized last year. In Korea and across the Northern Hemisphere, the last flu season, which would have taken off around November and run through spring, was almost non-existent.  Widespread behavioral changes such as crowd avoidance, hand hygiene and masking put in place to keep COVID-19 at bay seem to have stifled othe

The pandemic has opened up a window of opportunity for South Korean pharmaceutical and biotech companies to advance to the global stage. Several local players posted strong earnings by exporting self-developed test kits to foreign countries and secured contract manufacturing deals for COVID-19 vaccines. As a result, the number of pharmaceutical and biotech firms with sales exceeding 1 trillion won ($860.2 million) has increased to nine in 2020 from six a year earlier. Contract development

Vaccinations for people aged 17 to 49 will start Monday, as South Korea struggles to clamp down a fourth wave of the coronavirus. The upcoming vaccine roll out will be crucial in the country’s plan to reach herd immunity by November, the Korea Disease Control and Prevention Agency said, as it covers over 16 million people considered the most socially active among all age groups. Eligible are those born after Jan. 1, 1972, and before Dec. 31, 2003, a group that includes some 17-year-old

Why leaders need to crack down on toxic work culture

“Meokbang” (also known as “mukbang”), a compound word for “eating” and “broadcast” in Korean, is a popular form of content found on video platforms such as Youtube, AfreecaTV, Twitch, and Kakao TV. Meokbang streamers show themselves consuming large platefuls of junk food while simultaneously interacting with viewers. Along with the rise of one-person households in the country, people have gotten in the habit of watching meokbang while eating alon

South Korean researchers became the world’s first to discover a gene variant that causes a rare type of hearing impairment whose origins had so far remained unknown. The newly identified gene will help doctors better treat patients with auditory neuropathy spectrum disorder, or ANSD, and to find out if their condition can be improved through surgery, according to Dr. Choi Byung-yoon, Seoul National University Bundang Hospital’s otorhinolaryngology professor who led the research.

Having more than three cups of coffee a day can help those in their 40s or older live longer, researchers from Chung-Ang University found in a study with the Korea Disease Control and Prevention Agency. The study was conducted on 110,920 individuals older than 40. Scientists tracked the patients’ daily coffee intake and death rate for an average of 9.1 years. Individuals already diagnosed with diabetes, cardiovascular disease and cancer were not included in the study. The study conclude

South Korea's drug safety agency said Friday that it has begun reviewing a plasma therapy treatment against the novel coronavirus by local biotech company GC Pharma for conditional approval. The plasma therapy, dubbed GC5131A, is a type of hyperimmune globulin drug that uses blood plasma taken from people who have fully recovered from COVID-19, according to the Ministry of Food and Drug Safety. If approved, the investigative drug will be the country's first blood plasma cure for the deadly d